ALNY
Alnylam Pharmaceuticals Inc.
$446.51
-$5.82(-1.29%)
68
Overall
40
Value
100
Tech
65
Quality
Market Cap
$59.14B
Volume
827.61K
52W Range
$205.87 - $469.81
Target Price
$436.15
Key Metrics Overview
| Market Cap | $59.14B | P/E Ratio | 1014.80 |
| 52W High | $469.81 | 52W Low | $205.87 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 25.8% | 52W Position | 91.2% |
| Overall Score | 68 | Value Score | 40 |
| Quality Score | 65 | Technical Score | 100 |
Growth Analysis
| EPS Current Est | $0.44 | EPS Next Est | $5.5 |
| EPS Growth Est | +1150.0% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $446.51 | -1.3% | 827.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW